Dachaigh › Adenocarcinoma Esophageach › Pennsylvania › Pittsburgh
Sgrùdaidhean clionaigeach Adenocarcinoma Esophageach ann an Pittsburgh, PA
Tha 8 sgrùdaidhean airson Adenocarcinoma Esophageach a’ lorg phàirtichean aig làraichean ann agus timcheall air Pittsburgh (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
A’ fastadhÌre 2/3
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- agus 4 a bharrachd
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A’ fastadhÌre 2/3
- UPMC Hillman Cancer Center, Pittsburgh
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
A’ fastadh
- University of Pittsburgh Medical Center, Pittsburgh
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
A’ fastadhÌre 3
- Research Site, Pittsburgh
- Research Site, Pittsburgh
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- University of Pittsburg Medical Center _UPMC Hillman Cancer Center, Pittsburgh
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
A’ fastadhÌre 2
- UPMC Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
A’ fastadhÌre 2
- UPMC Hillman Cancer Center, Pittsburgh
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
A’ fastadhÌre 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Sgrùdaidhean Adenocarcinoma Esophageach ann am bailtean eile
- New York City, NY18 sgrùdaidhean
- Boston, MA13 sgrùdaidhean
- Houston, TX12 sgrùdaidhean
- Nashville, TN11 sgrùdadh
- Arlington, VA11 sgrùdadh
- Durham, NC10 sgrùdaidhean
- Rochester, MN9 sgrùdaidhean
- Baldwin Park, CA9 sgrùdaidhean
- St. Louis, MO9 sgrùdaidhean
- Jacksonville, FL9 sgrùdaidhean
- Queens, NY9 sgrùdaidhean
- Los Angeles, CA9 sgrùdaidhean
Sgrùdaidhean eile ann an Pittsburgh
- Aillse Sgamhain Neo-chealla-beag48 sgrùdaidhean
- Aillse (gach seòrsa)41 sgrùdaidhean
- Aillse a' bhroilleach39 sgrùdaidhean
- Aillse colorectal32 sgrùdaidhean
- Ailse metastatach31 sgrùdaidhean
- Melanoma31 sgrùdaidhean
- Cancer Ovarian30 sgrùdaidhean
- Ailse Endometrial23 sgrùdaidhean
- Aillse Prostata23 sgrùdaidhean
- Ailseachadh nan Sgamhan23 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil22 sgrùdaidhean
- Buailteach22 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.